Pruritus Therapeutics Market - Global Industry Analysis

Pruritus Therapeutics Market- By Product (Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressant, and Calcineurin Inhibitors) and By Disease Type (Atopic Dermatitis, Allergic Contact Dermatitis, and Urticaria): Global Industry Perspective, Comprehensive Analysis, And Forecast, 2022–2028

Published Date: 14-Mar-2022 Category: Pharmaceutical Report Format : PDF Pages: 170 Report Code: ZMR-531 Status : Published

The global Pruritus Therapeutics Market accrued earnings worth approximately 10.1 (USD Billion) in 2021 and is predicted to gain revenue of about 22.30 (USD Billion) by 2028, is set to record a CAGR of nearly 4.9% over the period from 2022 to 2028.

Description

The global Pruritus Therapeutics Market accrued earnings worth approximately 10.1 (USD Billion) in 2021 and is predicted to gain revenue of about 22.30 (USD Billion) by 2028, is set to record a CAGR of nearly 4.9% over the period from 2022 to 2028. The study provides assessment and analysis of the Pruritus Therapeutics Market on a global & regional level. It offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2021 along with a forecast from 2022 to 2028 based on revenue (USD Billion).

Pruritus Therapeutics Market: Overview

Pruritus is an unpleasant sensation and a most common skin disease symptom leading an individual to scratch skin. It is a cutaneous symptom and if it is ignored can lead to chronic pain as well as severely impact quality of life. For instance, pruritus can cause sleep disturbance, anxiety, and attention-deficit or hyperactivity disorder. Furthermore, if left untreated it can cause psychiatric and systemic ailments. According to NIH researchers, studies have revealed that hemodialysis individuals prone to more itching have more probability that their lifespan can be reduced.

Furthermore, chronic pruritus, which is one of key dermatology symptoms, is intractable and has huge impact on quality of life. Apart from this, the ailment is associated with psychological, systemic, and neurologic disorders. As per reports, pathogenesis of chronic pruritus is acute and can result in inflammation in cell tissues. Additionally, increase in knowledge of chronic pruritus pathogenesis coupled with access to high quality data from clinical experiments has resulted in emergence of new therapies for treating pruritus. These drug treatments are also anticipated to be utilized in routine dermatology medical practice.  They are opioidergic medicines such as kappa-opioid agonists & mu-opioid antagonists, Janus Kinase inhibitors, neurokinin-1 receptor antagonists, biologic medicines, histamine H4 receptor antagonists, ileal bile acid transport inhibitors, and aryl hydrocarbon receptor agonists.

Global Pruritus Therapeutics Market

Pruritus Therapeutics Market: Growth Drivers

Rise in occurrence of skin itching symptoms causing psoriasis, dermatitis, and urticarial will drive pruritus therapeutics market growth. In addition to this, high unmet healthcare requirements and launching of novel products including Bilastine and REMITECH drugs are predicted to contribute majorly towards market profits. Low drug costs and willingness of subjects to take treatment will prompt expansion of industry in next few years. High opportunity costs for treating skin diseases such as psoriasis will proliferate expansion of pruritus therapeutics industry over ensuing years.

In addition to this, large-scale use of barrier repair creams, moisturizers, and emollients is a key to pruritus treatment and helps in minimizing pruritus with help of enhanced barrier activities. Furthermore, topical corticosteroids are utilized for providing relief to patients having itching sensations and inflammatory skin ailments including psoriasis. However, topical calcineurin inhibitors, pimecrolimus, and tacrolimus have proved to be effective in alleviating pruritus in subjects suffering from atopic dermatitis. Additionally, azathioprine, doxepins, cyclosporine, oral antihistamines, menthol, capsaicin, topical salicylic acid, neuroleptics, aprepitant, and topical cannabinoids have proved effective in treatment of pruritus. All these aforementioned aspects will result in enlarged expansion of pruritus therapeutics market. Clinical studies have proved that drugs such as NGX-100, TS-022, and Methylnaltrexone have huge potential of effectively treating pruritus, thereby steering market trends.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Pruritus Therapeutics Market: Regional Landscape

North America To Account Majorly Towards Regional Market Share By 2028

Growth of regional market over forecasting timeline can be credited to launching of new therapeutic products and approval of generic medicines by U.S. FDA for treating pruritus & chronic pruritus such as psoriasis. Apart from this, supportive government regulations pertaining to pruritus treatment will spur regional market surge. According to NIH researchers, in 2011, occurrence of psoriasis in the U.S. was nearly 20% in children and about 4% in grown-ups.

Pruritus Therapeutics Market: Competitive Landscape

Key players influencing market growth and included in report are Brunswick Corporation, Precor Incorporated, Johnson Health Tech Co. Ltd., Technogym, Nautilus Strength, Icon Health & Fitness, Amer Sports Oyji, and Cybex International Inc.

The global Pruritus Therapeutics Market is segmented as follows:

By Product

  • Corticosteroids

  • Antihistamines
  • Local Anesthetics
  • Counterirritants
  • Immunosuppressant
  • Calcineurin Inhibitors

By Disease Type

  • Atopic Dermatitis

  • Allergic Contact Dermatitis
  • Urticaria

By Region

  • North America

    • The U.S.
    • Canada
  • Europe
    • France 
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report Description And Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Global Pruritus Therapeutics Market, 2014 - 2022 (USD Billion)
    • 2.2. Global Pruritus Therapeutics Market: Snapshot
  • Chapter 3. Pruritus Therapeutics Market – Market Dynamics
    • 3.1. Introduction
    • 3.2. Value Chain Analysis
    • 3.3. Market Drivers
      • 3.3.1. Global Pruritus Therapeutics Market drivers: Impact Analysis
      • 3.3.2. increasing prevalence of atopic dermatitis
      • 3.3.3. Development of new drug and a strong pipeline
    • 3.4. Global Pruritus Therapeutics Market Restraints: Impact Analysis
      • 3.4.1. Lack of awareness about pruritus
    • 3.5. Opportunities
      • 3.5.1. Untapped market and increasing number of patent expiry of pruritus drugs
    • 3.6. Porter’s Five Forces Analysis
      • 3.6.1. Bargaining Power Of Suppliers
      • 3.6.2. Bargaining Power Of Buyers
      • 3.6.3. Threat From New Entrants
      • 3.6.4. Threat From New Substitutes
      • 3.6.5. Degree Of Competition
    • 3.7. Market Attractiveness Analysis
      • 3.7.1. Market Attractiveness Analysis, by therapeutic segment
      • 3.7.2. Market Attractiveness Analysis, by Regional Segment
  • Chapter 4. Global Pruritus Therapeutics Market – Competitive Landscape
    • 4.1. Company Market Share, 2014 (Subject To Data Availability)
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Source Launch
      • 4.2.3. Agreements, Partnerships, Collaborations And Joint Ventures
      • 4.2.4. Research And Development, Therapeutic And Regional Expansion
    • 4.3. Technology Portfolio
    • 4.4. Patent Analysis (2011-2015)
      • 4.4.1. Patent Trend
      • 4.4.2. Patent Share By Company
      • 4.4.3. By Region
  • Chapter 5. Global Pruritus Therapeutics Market – Therapeutic Analysis
    • 5.1. Global Pruritus Therapeutics Market: Therapeutic Segment Overview
      • 5.1.1. Global Pruritus Therapeutics Market Revenue Share, By Therapeutic Segment, 2014 And 2022
    • 5.2. Antihistamines
      • 5.2.1. Global Pruritus Therapeutics Market For Antihistamines, 2014 - 2022 (USD Billion)
    • 5.3. Topical Corticosteroids
      • 5.3.1. Global Pruritus Therapeutics Market For Topical Corticosteroids, 2014 - 2022 (USD Billion
    • 5.4. Opioid Receptor Antagonists
      • 5.4.1. Global Pruritus Therapeutics Market For Opioid Receptor Antagonists, 2014 - 2022 (USD Billion)
    • 5.5. Topical Immunomodulators
      • 5.5.1. Global Pruritus Therapeutics Market For Topical Immunomodulators, 2014 - 2022 (USD Billion)
    • 5.6. Antidepressants
      • 5.6.1. Global Pruritus Therapeutics Market For Antidepressants , 2014 - 2022 (USD Billion)
    • 5.7. Immunosuppressants
      • 5.7.1. Global Pruritus Therapeutics Market For Immunosuppressants, 2014 - 2022 (USD Billion)
    • 5.8. Topical Local Anesthetics
      • 5.8.1. Global Pruritus Therapeutics Market For Topical Local Anesthetics, 2014 - 2022 (USD Billion)
    • 5.9. Cannabinoid Receptors
      • 5.9.1. Global Pruritus Therapeutics Market For Cannabinoid Receptors, 2014 - 2022 (USD Billion)
    • 5.10. Others
      • 5.10.1. Global Pruritus Therapeutics Market For others, 2014 - 2022 (USD Billion)
  • Chapter 6. Global Pruritus Therapeutics Market – Regional Segment Analysis
    • 6.1. Global Pruritus Therapeutics Market: Regional Overview
      • 6.1.1. Global Pruritus Therapeutics Market Revenue Share, By Region, 2014 And 2020
    • 6.2. North America
      • 6.2.1. North America Pruritus Therapeutics Market Revenue, by therapeutic 2014 - 2022 , (USD Billion)
      • 6.2.2. U.S.
        • 6.2.2.1. U.S. Pruritus Therapeutics Market Revenue, by therapeutic type classification, 2014 - 2022 , (USD Million)
    • 6.3. Europe
      • 6.3.1. Europe Pruritus Therapeutics Market Revenue, by therapeutic 2014 - 2022 , (USD Billion)
      • 6.3.2. U.K.
        • 6.3.2.1. U.K. Pruritus Therapeutics Market Revenue, by therapeutic type classification, 2014 - 2022 , (USD Million)
      • 6.3.3. Germany
        • 6.3.3.1. Germany Pruritus Therapeutics Market Revenue, by therapeutic type classification, 2014 - 2022 , (USD Million)
      • 6.3.4. France
        • 6.3.4.1. France Pruritus Therapeutics Market Revenue, by therapeutic type classification, 2014 - 2022 , (USD Million)
    • 6.4. Asia Pacific
      • 6.4.1. Asia Pacific Pruritus Therapeutics Market Revenue, by therapeutic 2014 - 2022 , (USD Billion)
      • 6.4.2. India
        • 6.4.2.1. India Pruritus Therapeutics Market Revenue, by therapeutic type classification, 2014 - 2022 , (USD Million)
      • 6.4.3. China
        • 6.4.3.1. China Pruritus Therapeutics Market Revenue, by therapeutic type classification, 2014 - 2022 , (USD Million)
      • 6.4.4. Japan
        • 6.4.4.1. Japan Pruritus Therapeutics Market Revenue, by therapeutic type classification, 2014 - 2022 , (USD Million)
    • 6.5. Latin America
      • 6.5.1. Latin America Pruritus Therapeutics Market Revenue, by therapeutic 2014 - 2022 , (USD Billion)
      • 6.5.2. Brazil
        • 6.5.2.1. Brazil Pruritus Therapeutics Market Revenue, by therapeutic type classification, 2014 - 2022 , (USD Million)
    • 6.6. Middle East and Africa
      • 6.6.1. Middle East and Africa Pruritus Therapeutics Market Revenue, by therapeutic 2014 - 2022 , (USD Billion)
  • Chapter 7. Company Profile
    • 7.1. Allergan Inc.
      • 7.1.1. Overview
      • 7.1.2. Financials
      • 7.1.3. Technology Portfolio
      • 7.1.4. Business Strategy
      • 7.1.5. Recent Developments
    • 7.2. Amgen Inc.
      • 7.2.1. Overview
      • 7.2.2. Financials
      • 7.2.3. Technology Portfolio
      • 7.2.4. Business Strategy
      • 7.2.5. Recent Developments
    • 7.3. Astellas Pharma Inc.
      • 7.3.1. Overview
      • 7.3.2. Financials
      • 7.3.3. Technology Portfolio
      • 7.3.4. Business Strategy
      • 7.3.5. Recent Developments
    • 7.4. CARA Therapeutics
      • 7.4.1. Overview
      • 7.4.2. Financials
      • 7.4.3. Technology Portfolio
      • 7.4.4. Business Strategy
      • 7.4.5. Recent Developments
    • 7.5. Novartis AG
      • 7.5.1. Financials
      • 7.5.2. Technology Portfolio
      • 7.5.3. Business Strategy
      • 7.5.4. Recent Developments
    • 7.6. Teva Pharmaceutical Industries Ltd.
      • 7.6.1. Financials
      • 7.6.2. Technology Portfolio
      • 7.6.3. Business Strategy
      • 7.6.4. Recent Developments
    • 7.7. Ajanta Pharma ltd.
      • 7.7.1. Overview
      • 7.7.2. Financials
      • 7.7.3. Technology Portfolio
      • 7.7.4. Business Strategy
      • 7.7.5. Recent Developments
    • 7.8. Abbot lab
      • 7.8.1. Overview
      • 7.8.2. Financials
      • 7.8.3. Technology Portfolio
      • 7.8.4. Business Strategy
      • 7.8.5. Recent Developments
    • 7.9. GlaxoSmithKline plc.
      • 7.9.1. Overview
      • 7.9.2. Financials
      • 7.9.3. Technology Portfolio
      • 7.9.4. Business Strategy
      • 7.9.5. Recent Developments
    • 7.10. Galderma
      • 7.10.1. Overview
      • 7.10.2. Financials
      • 7.10.3. Technology Portfolio
      • 7.10.4. Business Strategy
      • 7.10.5. Recent Developments

Table Of Figures

List of Figures

1. Market Research Process
2. Market Research Methodology
3. Global Pruritus Therapeutics Market Revenue, 2014 - 2022 (USD Billion) 
4. Porter’s Five Forces Analysis
5. Global Pruritus Therapeutics Market: Market Attractiveness Analysis, by technology type Segment
6. Global Pruritus Therapeutics Market: Market Attractiveness Analysis, by Regional Segment
7. Company Market Share Analysis, 2014 and 2022 
8. Global Pruritus Therapeutics Market Revenue Share, by Therapeutic type, 2014 And 2022
9. Global Pruritus Therapeutics Market For Antihistamines, 2014 - 2022  (USD Billion) 
10. Global Pruritus Therapeutics Market For Topical Corticosteroids, 2014 - 2022  (USD Billion)
11. Global Pruritus Therapeutics Market For Opioid Receptor Antagonists, 2014 - 2022  (USD Billion)
12. Global Pruritus Therapeutics Market For Topical Immunomodulators, 2014 - 2022  (USD Billion)
13. Global Pruritus Therapeutics Market For Antidepressants, 2014 - 2022  (USD Billion) 
14. Global Pruritus Therapeutics Market For Immunosuppressants, 2014 - 2022  (USD Billion) 
15. Global Pruritus Therapeutics Market For Topical Local Anesthetics, 2014 - 2022  (USD Billion) 
16. Global Pruritus Therapeutics Market For Cannabinoid Receptors, 2014 - 2022  (USD Billion) 
17. Global Pruritus Therapeutics Market For others, 2014 - 2022  (USD Billion)
18. Global Pruritus Therapeutics Market Share, By Region, 2014 - 2022
19. North America Pruritus Therapeutics Market, 2014 - 2022, (USD Billion)
20. U.S. Pruritus Therapeutics Market, 2014 - 2022, (USD Million)
21. Europe Pruritus Therapeutics Market, 2014 - 2022, (USD Billion)
22. U.K. Pruritus Therapeutics Market, 2014 - 2022, (USD Million)
23. Germany Pruritus Therapeutics Market, 2014 - 2022, (USD Million)
24. France Pruritus Therapeutics Market, 2014 - 2022, (USD Million)
25. Asia Pacific Pruritus Therapeutics Market, 2014 - 2022, (USD Billion)
26. India Pruritus Therapeutics Market, 2014 - 2022, (USD Million)
27. China Pruritus Therapeutics Market, 2014 - 2022, (USD Million)
28. Japan Pruritus Therapeutics Market, 2014 - 2022, (USD Million)
29. Latin America Pruritus Therapeutics Market, 2014 - 2022, (USD Billion)
30. Brazil Pruritus Therapeutics Market, 2014 - 2022, (USD Million)
31. Middle East & Africa Pruritus Therapeutics Market, 2014 - 2022, (USD Billion)


Table Of Tables

List of Tables

1. Pruritus Therapeutics Market: Market Snapshot
2. Drivers Of Global Pruritus Therapeutics Market: Impact Analysis 
3. Restraints Of Global Pruritus Therapeutics Market: Impact Analysis  
4. North America Pruritus Therapeutics Market Revenue, by therapeutic  2014 - 2022 , (USD Billion) 
5. U.S. Pruritus Therapeutics Market Revenue, by therapeutic  2014 - 2022 , (USD Million) 
6. Europe Pruritus Therapeutics Market Revenue, by therapeutic  2014 - 2022 , (USD Billion) 
7. U.K. Pruritus Therapeutics Market Revenue, by therapeutic  2014 - 2022 , (USD Million) 
8. Germany Pruritus Therapeutics Market Revenue, by therapeutic  2014 - 2022 , (USD Million) 
9. France Pruritus Therapeutics Market Revenue, by therapeutic  2014 - 2022 , (USD Million) 
10. Asia Pacific Pruritus Therapeutics Market Revenue, by therapeutic  2014 - 2022 , (USD Billion) 
11. India Pruritus Therapeutics Market Revenue, by therapeutic type  2014 - 2022 , (USD Million) 
12. China Pruritus Therapeutics Market Revenue, by therapeutic type  2014 - 2022 , (USD Million) 
13. Japan Pruritus Therapeutics Market Revenue, by therapeutic type  2014 - 2022 , (USD Million) 
14. Latin America Pruritus Therapeutics Market Revenue, by therapeutic  2014 - 2022 , (USD Billion) 
15. Brazil Pruritus Therapeutics Market Revenue, by therapeutic type2014 - 2022 , (USD Million) 
16. Middle East and Africa Pruritus Therapeutics Market Revenue, by therapeutic  2014 - 2022 , (USD Billion)

Methodology

This report is based on in-depth qualitative and quantitative analyses of the global Pruritus Therapeutics market. Zion Research has collected and analyzed key data belong to the global Pruritus Therapeutics market using a variety of methods. Quantitative analysis has been done following various projection and sampling techniques.

The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions. The market dynamics have been determined after conducting a detailed study of the micro and macroeconomic indicators of the market.

Various parameters have been taken into account while estimating market size. The revenue generated by the leading industry participants in from the sales of Pruritus Therapeutics across the world has been calculated through primary and secondary research.

Zion Research employs the combination of secondary research followed by extensive primary research. Under secondary research, we refer to prominent paid as well as open access data sources including product literature, company annual reports, government publications, press releases, industry association’s magazines and other relevant sources for data collection. Other prominent secondary sources include STATISTA, trade journals, trade associations, statistical data from government websites, etc. 

For this study, Zion Research has conducted all-encompassing primary research with key industry participants to collect first had data. Moreover, in-depth interviews with key opinion leaders also assisted in the validation of findings from secondary research and to understand key trends in the Pruritus Therapeutics industry. Primary research makes up the major source of data collection and validation.   

Primary Research

We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides firsthand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening the secondary research findings
  • Further, develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies

Participants who typically participate in such a process include, but are not limited to:

  • Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and national sales managers
  • Purchasing managers, technical personnel, distributors and resellers
  • Outside experts: Investment bankers, valuation experts and research analysts specializing in specific markets

Key opinion leaders specializing in different areas corresponding to different industry verticals

Secondary Research

Secondary research sources that are typically referred to include, but are not limited to:

  • Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
  • IDC and other relevant magazines
  • Internal and external proprietary databases, and relevant patent and regulatory databases
  • National government documents, statistical databases and market reports

News articles, press releases and webcasts specific to companies operating in the market

Following a comprehensive secondary and primary research and insights thus gathered, analysts at Zion Research have provided an in-depth analysis of various aspects of the Pruritus Therapeutics market.

Models

Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:

  • Demographic data: Population split by segments
  • Macroeconomic indicators: GDP, PPP, Per Capita Income, etc.
  • Industry indicators: Expenditure, technology stage and infrastructure, sector growth and facilities
  • Data is then cross-checked by an expert panel.

Free Analysis

Pruritus is the medical term for itchy skin. Pruritus is the most common dermatological disorder. Pruritus is a normal body reaction to protect from harmful external parasites or substances such as insect bites. However, it can be as a result of wide range of skin diseases. Pruritus lasting for more than 6 weeks is called chronic pruritus. Pruritus has been classified into the following four key types include neuropathic, cutaneous, psychogenic and neurogenic. Chronic renal failure is a vital cause of persistent pruritus. Pruritus is enhanced or provoked by a number of chemical substances such as prostaglandins, cytokines, histamine, proteases, neuropeptides and bile salts. Furthermore, chronic pruritus is becoming a burden to society mainly due to the treatment-related costs, which is particularly high due to the elevation rate of therapeutic failure.

Atopic dermatitis is also known as eczema. This is one of the most common skin diseases found in children. Itching may cause skin darkening & thickening and lead to further complications including bacterial infection. In atopic dermatitis, the primary skin becomes extremely inflamed & itchy causing swelling, redness, vesicle formation, cracking, crusting, weeping, and scaling. Thus, pruritus therapeutics market is mainly driven by increasing the prevalence of atopic dermatitis. Moreover, development of new drug and a strong pipeline is also expected to propel the market growth in the years. However, lack of awareness about pruritus may hamper the growth of pruritus therapeutics market. Nonetheless, untapped market and an increasing number of patent expiry of pruritus drugs may generate new opportunity in the forecast period.

The market of pruritus therapeutics has been segmented into antihistamines, topical corticosteroids, opioid receptor antagonists, topical immunomodulators, antidepressants, immunosuppressants, topical local anesthetics, cannabinoid receptors and others. Topical corticosteroids segment dominated the market with more than 20% market share in 2014 while antidepressants segment expected to witness exponential growth in the forecast period. Topical corticosteroids are mostly used to provide relief of itching associated with inflammatory skin diseases such as atopic dermatitis or psoriasis.

Based on region, the pruritus therapeutics market is classified into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. As a result of favorable government initiatives and introduction of new products for pruritus treatments, North America dominated the market in 2014. Europe was the second largest segment in pruritus therapeutics market and is projected to grow at a steady growth rate.

Key players operating in the global pruritus therapeutics market include Allergan Inc., Amgen Inc., Astellas Pharma Inc., CARA Therapeutics, Novartis AG, and Teva Pharmaceutical Industries Ltd., Ajanta Pharma ltd, Abbot Lab, GSK and Galderma.

Choose License Type

FrequentlyAsked Questions

Rise in occurrence of skin itching symptoms causing psoriasis, dermatitis, and urticarial will drive pruritus therapeutics market trends.

   

According to Zion market research report, The global Pruritus Therapeutics Market accrued earnings worth approximately 10.1 (USD Billion) in 2021 and is predicted to gain revenue of about 22.30 (USD Billion) by 2028, is set to record a CAGR of nearly 4.9% over the period from 2022 to 2028.

North America will contribute lucratively towards the global market revenue over the projected timeline. Expansion of Pruritus Therapeutics Market in region can be credited to launching of new therapeutic products and approval of generic medicines by U.S. FDA for treating pruritus & chronic pruritus such as psoriasis.

The key market participants leveraging business sphere include Brunswick Corporation, Precor Incorporated, Johnson Health Tech Co. Ltd., Technogym, Nautilus Strength, Icon Health & Fitness, Amer Sports Oyji, and Cybex International Inc.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed